Teenagers Are Taking New Weight-Loss Drugs, but the Science Is Far from Settled
Wegovy and similar weight-loss medications are becoming widely prescribed for teenagers with obesity, but little is known about their long-term effects
Weight-loss drugs didn't curb health costs within two years
Drugs like Wegovy may trim your waistline but not medical costs, according to an analysis of U.S. health insurance claims shared with Reuters.
Popular weight-loss drugs cause wastage in vital skeletal muscle
Rapid weight loss can cause a greater loss of muscle mass than losing weight slowly. The popularity of newer weight-loss drugs that shed pounds quickly has raised concerns among researchers about how this will affect the health of our muscles,
The Truth About Weight Loss Drugs
Here's what to know about weight loss drugs such as Wegovy and Zepbound. CR helps you decide whether semaglutide or tirzepatide is right for you.
Competition will make weight-loss drugs better, cheaper and bigger
A mong the many newcomers to the business of weight-loss drugs is Hims & Hers, an American e-pharmacy better known for hawking remedies for erectile dysfunction and hair loss. Since May it has offered its own version of Wegovy,
Weight-Loss Drugs May Help Alcohol and Opioid Addiction
Research hints that medications like Zepbound and Wegovy could provide new ways to treat opioid and alcohol abuse.
Weight-loss surgeries decline 25% as GLP-1 drugs grow in popularity
As the popularity of GLP-1 meds like Wegovy and Zepbound grows, fewer Americans are turning to weight-loss surgeries to trim their waistlines, a new report finds.
Big Food Is Learning to Love Weight-Loss Drugs
A new class of weight-loss drugs is changing the food industry, but not in the way many expected at first. They could present just as many opportunities as pitfalls. People taking the drugs do indeed eat less—especially indulgent treats.
Weight-loss drugs could reduce risk of overdoses, new study says
A new study suggests that medications like Ozempic could help reduce the risk of overdose and alcohol intoxication in people with substance use disorders.
Opinion
New weight loss drugs raise questions of access, costs
New, popular injectable weight loss drugs — GLP-1 drugs — are highly effective at reducing obesity and, probably, the health risks posed by obesity. Yet the drugs are so expensive that insurers are often choosing between two bad options: restricting access or raising consumer costs.
In the era of GLP-1 drugs, demand for bariatric surgery plunges
The findings spell an uncertain future for hospitals and clinics that derive a significant portion of their revenues from obesity procedures.
Weight loss care is leading IPO-hopeful Omada Health's latest growth surge as Ozempic boom continues
Employers are rushing to Omada to get the startup's help managing patients on costly drugs like Ozempic.
People Are Selling Weight-Loss Drugs on Facebook. Doctors Warn They Could Be Fakes—and Buyers Could Face Jail Time
A new report found people selling leftover weight loss drugs, like Ozempic or Mounjaro, on Facebook. Doctors are ...
Lizzo’s Halloween costume draws inspiration from ‘South Park’ episode that referenced her and the weight-loss drug Ozempic
Lizzo has taken a rather silly reference to her on a recent “South Park” episode and elevated it to a hilarious Halloween ...
Lilly's weight loss drug shortage deemed over, but hurdles remain
Some patients fear tirzepatide, sold by Eli Lilly under the brand names Zepbound and Mounjaro, will be hard to get and ...
Novo Nordisk asks US to stop compounding pharmacies from making weight-loss drug copies
Novo Nordisk on Tuesday asked the U.S. Food and Drug Administration to ban compounding pharmacies from making copycat ...